Denne side blev automatisk oversat, og nøjagtigheden af ​​oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

En global fase III-undersøgelse af rilvegostomig eller pembrolizumab monoterapi til førstelinjebehandling af PD-L1-høj metastatisk ikke-småcellet lungekræft (ARTEMIDELung04)

24. september 2026 opdateret af: AstraZeneca

En fase III, randomiseret, dobbeltblind, multicenter, global undersøgelse af rilvegostomig eller pembrolizumab monoterapi til den første linjebehandling af patienter med PD-L1-høj metastatisk ikke-småcellet lungekræft (Artemide-Lung04)

The purpose of ARTEMIDE-Lung04 is to assess the efficacy and safety of rilvegostomig compared with pembrolizumab monotherapy as 1L treatment in participants with mNSCLC and whose tumors express PD-L1.

Studieoversigt

Status

Rekruttering

Detaljeret beskrivelse

This is a Phase III, two-arm, randomized, double-blind, global, multicenter study assessing the efficacy and safety of rilvegostomig compared to pembrolizumab as a 1L treatment for patients with mNSCLC whose tumors express PD-L1.

Undersøgelsestype

Interventionel

Tilmelding (Anslået)

830

Fase

  • Fase 3

Kontakter og lokationer

Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.

Studiekontakt

Studiesteder

      • CABA, Argentina, 1425
        • Rekruttering
        • Research Site
      • Córdoba, Argentina, 5000
        • Rekruttering
        • Research Site
      • Pilar, Argentina, B1629AHJ
        • Rekruttering
        • Research Site
      • Rosario, Argentina, S2000CVB
        • Rekruttering
        • Research Site
      • Rosario, Argentina, 2000
        • Rekruttering
        • Research Site
      • Viedma, Argentina, R8500ACE
        • Rekruttering
        • Research Site
      • Hobart, Australien, 7000
        • Trukket tilbage
        • Research Site
      • Woolloongabba, Australien, 4102
        • Trukket tilbage
        • Research Site
      • Edegem, Belgien, 2650
        • Rekruttering
        • Research Site
      • Jette, Belgien, 1090
        • Rekruttering
        • Research Site
      • Libramont-Chevigny, Belgien, 6800
        • Rekruttering
        • Research Site
      • Liège, Belgien, 4000
        • Rekruttering
        • Research Site
      • Mechelen, Belgien, 2800
        • Rekruttering
        • Research Site
      • Roeselaere, Belgien, 8800
        • Rekruttering
        • Research Site
      • Blumenau, Brasilien, 89010-340
        • Rekruttering
        • Research Site
      • Fortaleza, Brasilien, 60336-550
        • Rekruttering
        • Research Site
      • Ijuí, Brasilien, 98700-000
        • Rekruttering
        • Research Site
      • Itajaí, Brasilien, 88301-220
        • Rekruttering
        • Research Site
      • Londrina, Brasilien, 86015-520
        • Rekruttering
        • Research Site
      • Passo Fundo, Brasilien, 99010-260
        • Rekruttering
        • Research Site
      • Porto Alegre, Brasilien, 90035-903
        • Rekruttering
        • Research Site
      • Porto Alegre, Brasilien, 90610-000
        • Rekruttering
        • Research Site
      • Porto Velho, Brasilien, 76834-899
        • Rekruttering
        • Research Site
      • Salvador, Brasilien, 41950-640
        • Rekruttering
        • Research Site
      • Salvador, Brasilien, 41253-190
        • Rekruttering
        • Research Site
      • Santo André, Brasilien, 09060-650
        • Rekruttering
        • Research Site
      • São Paulo, Brasilien, 01246-000
        • Rekruttering
        • Research Site
      • São Paulo, Brasilien, 04501-000
        • Rekruttering
        • Research Site
      • Teresina, Brasilien, 64049-200
        • Rekruttering
        • Research Site
      • Burgas, Bulgarien, 8000
        • Rekruttering
        • Research Site
      • Panagyurishte, Bulgarien, 4500
        • Rekruttering
        • Research Site
      • Sofia, Bulgarien, 1407
        • Rekruttering
        • Research Site
      • Sofia, Bulgarien, 1756
        • Rekruttering
        • Research Site
      • Sofia, Bulgarien, 1618
        • Rekruttering
        • Research Site
      • Varna, Bulgarien, 9010
        • Ikke rekrutterer endnu
        • Research Site
    • Alberta
      • Edmonton, Alberta, Canada, T6G 1Z2
        • Rekruttering
        • Research Site
    • British Columbia
      • Kelowna, British Columbia, Canada, V1Y 5L3
        • Ikke rekrutterer endnu
        • Research Site
    • Ontario
      • Cambridge, Ontario, Canada, N1R 3G2
        • Ikke rekrutterer endnu
        • Research Site
      • Newmarket, Ontario, Canada, L3Y 2P9
        • Ikke rekrutterer endnu
        • Research Site
      • Toronto, Ontario, Canada, M4N 3M5
        • Rekruttering
        • Research Site
    • Quebec
      • Québec, Quebec, Canada, G1V 4G5
        • Ikke rekrutterer endnu
        • Research Site
      • Saint-Jérôme, Quebec, Canada, J7Z 5T3
        • Ikke rekrutterer endnu
        • Research Site
      • Conception, Chile, 4070196
        • Rekruttering
        • Research Site
      • Santiago, Chile, 7500653
        • Rekruttering
        • Research Site
      • Santiago, Chile, 8420383
        • Rekruttering
        • Research Site
      • Santiago, Chile, 7500713
        • Rekruttering
        • Research Site
      • Cali, Colombia, 760032
        • Rekruttering
        • Research Site
      • Floridablanca, Colombia, 680001
        • Rekruttering
        • Research Site
      • Medellín, Colombia, 050034
        • Rekruttering
        • Research Site
      • Valledupar, Colombia, 200001
        • Rekruttering
        • Research Site
      • San José, Costa Rica, 1000
        • Rekruttering
        • Research Site
      • San José, Costa Rica, 10108
        • Rekruttering
        • Research Site
      • San José Capital, Costa Rica, 1000
        • Rekruttering
        • Research Site
      • Santa Ana, Costa Rica, 10903
        • Rekruttering
        • Research Site
      • Blackpool, Det Forenede Kongerige, FY3 8NR
        • Rekruttering
        • Research Site
      • Glasgow, Det Forenede Kongerige, G12 0YN
        • Rekruttering
        • Research Site
      • Guildford, Det Forenede Kongerige, GU2 7XX
        • Rekruttering
        • Research Site
      • Hull, Det Forenede Kongerige, HU16 5JQ
        • Rekruttering
        • Research Site
      • Northwood, Det Forenede Kongerige, HA6 2RN
        • Rekruttering
        • Research Site
      • Oxford, Det Forenede Kongerige, OX4 6LB
        • Rekruttering
        • Research Site
    • California
      • La Mesa, California, Forenede Stater, 91942
        • Ikke rekrutterer endnu
        • Research Site
      • Los Alamitos, California, Forenede Stater, 90720
        • Ikke rekrutterer endnu
        • Research Site
    • Delaware
      • Newark, Delaware, Forenede Stater, 19713
        • Rekruttering
        • Research Site
    • Florida
      • Bay Pines, Florida, Forenede Stater, 33744
        • Rekruttering
        • Research Site
      • Clearwater, Florida, Forenede Stater, 33756
        • Rekruttering
        • Research Site
      • Gainesville, Florida, Forenede Stater, 32610
        • Rekruttering
        • Research Site
      • St. Petersburg, Florida, Forenede Stater, 33705
        • Rekruttering
        • Research Site
    • Georgia
      • Marietta, Georgia, Forenede Stater, 30060
        • Rekruttering
        • Research Site
    • Illinois
      • Chicago, Illinois, Forenede Stater, 60612
        • Rekruttering
        • Research Site
      • Decatur, Illinois, Forenede Stater, 62526
        • Rekruttering
        • Research Site
    • Iowa
      • Des Moines, Iowa, Forenede Stater, 50309
        • Rekruttering
        • Research Site
      • Waterloo, Iowa, Forenede Stater, 50702
        • Ikke rekrutterer endnu
        • Research Site
    • Kansas
      • Leawood, Kansas, Forenede Stater, 66209
        • Rekruttering
        • Research Site
    • Kentucky
      • Lexington, Kentucky, Forenede Stater, 40536
        • Ikke rekrutterer endnu
        • Research Site
      • Owensboro, Kentucky, Forenede Stater, 42303
        • Rekruttering
        • Research Site
    • Maryland
      • Bethesda, Maryland, Forenede Stater, 20817
        • Rekruttering
        • Research Site
      • Frederick, Maryland, Forenede Stater, 21702
        • Rekruttering
        • Research Site
      • Silver Spring, Maryland, Forenede Stater, 20910
        • Rekruttering
        • Research Site
      • Towson, Maryland, Forenede Stater, 21204
        • Rekruttering
        • Research Site
    • Michigan
      • Saginaw, Michigan, Forenede Stater, 48602
        • Ikke rekrutterer endnu
        • Research Site
    • Missouri
      • Bridgeton, Missouri, Forenede Stater, 63044
        • Rekruttering
        • Research Site
    • Nebraska
      • Lincoln, Nebraska, Forenede Stater, 68506
        • Rekruttering
        • Research Site
    • Nevada
      • Reno, Nevada, Forenede Stater, 89511
        • Rekruttering
        • Research Site
    • New Jersey
      • Paramus, New Jersey, Forenede Stater, 07652
        • Ikke rekrutterer endnu
        • Research Site
    • New York
      • Buffalo, New York, Forenede Stater, 14215
        • Rekruttering
        • Research Site
      • East Syracuse, New York, Forenede Stater, 13057
        • Rekruttering
        • Research Site
      • Fresh Meadows, New York, Forenede Stater, 11366
        • Rekruttering
        • Research Site
      • Rochester, New York, Forenede Stater, 14642
        • Ikke rekrutterer endnu
        • Research Site
      • Westbury, New York, Forenede Stater, 11590
        • Rekruttering
        • Research Site
    • Ohio
      • Canton, Ohio, Forenede Stater, 44718
        • Ikke rekrutterer endnu
        • Research Site
    • Pennsylvania
      • Fountain Hill, Pennsylvania, Forenede Stater, 18015
        • Rekruttering
        • Research Site
      • Kittanning, Pennsylvania, Forenede Stater, 16201
        • Ikke rekrutterer endnu
        • Research Site
      • Philadelphia, Pennsylvania, Forenede Stater, 19104
        • Rekruttering
        • Research Site
    • Texas
      • Round Rock, Texas, Forenede Stater, 78665
        • Ikke rekrutterer endnu
        • Research Site
    • Washington
      • Aberdeen, Washington, Forenede Stater, 98520
        • Rekruttering
        • Research Site
      • Renton, Washington, Forenede Stater, 98055
        • Ikke rekrutterer endnu
        • Research Site
    • West Virginia
      • Charleston, West Virginia, Forenede Stater, 25304
        • Rekruttering
        • Research Site
      • Morgantown, West Virginia, Forenede Stater, 26506
        • Rekruttering
        • Research Site
    • Wisconsin
      • Schofield, Wisconsin, Forenede Stater, 54476
        • Ikke rekrutterer endnu
        • Research Site
      • Angers, Frankrig, 49100
        • Ikke rekrutterer endnu
        • Research Site
      • Avignon, Frankrig, 84000
        • Rekruttering
        • Research Site
      • Boulogne-Billancourt, Frankrig, 92100
        • Rekruttering
        • Research Site
      • Caen, Frankrig, 14000
        • Rekruttering
        • Research Site
      • Chambéry, Frankrig, 73011
        • Rekruttering
        • Research Site
      • Dijon, Frankrig, 21000
        • Rekruttering
        • Research Site
      • La Tronche, Frankrig, 38700
        • Rekruttering
        • Research Site
      • Limoges, Frankrig, 87042
        • Rekruttering
        • Research Site
      • Nantes, Frankrig, 44093
        • Rekruttering
        • Research Site
      • Paris, Frankrig, 75020
        • Rekruttering
        • Research Site
      • Pau, Frankrig, 64046
        • Rekruttering
        • Research Site
      • St-Malo, Frankrig, 35403
        • Rekruttering
        • Research Site
      • Toulouse, Frankrig, 31300
        • Ikke rekrutterer endnu
        • Research Site
      • Tours, Frankrig, 37000
        • Rekruttering
        • Research Site
      • Tbilisi, Georgien, 0159
        • Rekruttering
        • Research Site
      • Tbilisi, Georgien, 0112
        • Rekruttering
        • Research Site
      • Tbilisi, Georgien, 160
        • Rekruttering
        • Research Site
      • Tbilisi, Georgien, 177
        • Rekruttering
        • Research Site
      • Athens, Grækenland, 12462
        • Rekruttering
        • Research Site
      • Athens, Grækenland, 11527
        • Rekruttering
        • Research Site
      • Athens, Grækenland, 115 27
        • Rekruttering
        • Research Site
      • Larissa, Grækenland, 411 10
        • Rekruttering
        • Research Site
      • Piraeus, Grækenland, 185 37
        • Rekruttering
        • Research Site
      • Piraeus, Grækenland, 185 47
        • Rekruttering
        • Research Site
      • Thessaloniki, Grækenland, 56429
        • Rekruttering
        • Research Site
      • Thessaloniki, Grækenland, 57001
        • Rekruttering
        • Research Site
      • Thessaloniki, Grækenland, 55236
        • Rekruttering
        • Research Site
      • Cork, Irland, T12 DFK4
        • Ikke rekrutterer endnu
        • Research Site
      • Dublin, Irland, D08 NHY1
        • Rekruttering
        • Research Site
      • Dublin, Irland, D24 NR0A
        • Rekruttering
        • Research Site
      • Dublin, Irland, D07 R2WY
        • Rekruttering
        • Research Site
      • Dublin, Irland, D09 V2N0
        • Rekruttering
        • Research Site
      • Dublin, Irland, DO4YN63
        • Rekruttering
        • Research Site
      • Galway, Irland, H91 YR71
        • Ikke rekrutterer endnu
        • Research Site
      • Afula, Israel, 1834111
        • Rekruttering
        • Research Site
      • Beersheba, Israel, 8410101
        • Rekruttering
        • Research Site
      • Hadera, Israel, 38100
        • Rekruttering
        • Research Site
      • Haifa, Israel, 34362
        • Rekruttering
        • Research Site
      • Haifa, Israel, 91096
        • Rekruttering
        • Research Site
      • Jerusalem, Israel, 91031
        • Rekruttering
        • Research Site
      • Jerusalem, Israel, 91120
        • Rekruttering
        • Research Site
      • Ramat Gan, Israel, 52621
        • Rekruttering
        • Research Site
      • Tel Aviv, Israel, 64239
        • Rekruttering
        • Research Site
      • Tel Aviv, Israel, 69710
        • Rekruttering
        • Research Site
      • Candiolo, Italien, 10060
        • Rekruttering
        • Research Site
      • Lecco, Italien, 23900
        • Rekruttering
        • Research Site
      • Lucca, Italien, 55100
        • Rekruttering
        • Research Site
      • Meldola, Italien, 47014
        • Rekruttering
        • Research Site
      • Milan, Italien, 20132
        • Rekruttering
        • Research Site
      • Milan, Italien, 20133
        • Ikke rekrutterer endnu
        • Research Site
      • Naples, Italien, 80131
        • Rekruttering
        • Research Site
      • Peschiera del Garda, Italien, 37019
        • Rekruttering
        • Research Site
      • Pisa, Italien, 56126
        • Rekruttering
        • Research Site
      • Roma, Italien, 00144
        • Rekruttering
        • Research Site
      • Torrette Di Ancona, Italien, 60126
        • Rekruttering
        • Research Site
      • Udine, Italien, 33100
        • Rekruttering
        • Research Site
      • Verona, Italien, 37126
        • Rekruttering
        • Research Site
      • Akashi, Japan, 673-8558
        • Rekruttering
        • Research Site
      • Bunkyō City, Japan, 113-8603
        • Rekruttering
        • Research Site
      • Bunkyō City, Japan, 113-8677
        • Rekruttering
        • Research Site
      • Fukuoka, Japan, 812-8582
        • Rekruttering
        • Research Site
      • Fukuoka, Japan, 811-1395
        • Rekruttering
        • Research Site
      • Hamamatsu, Japan, 431-3192
        • Rekruttering
        • Research Site
      • Iwakuni-shi, Japan, 740-8510
        • Rekruttering
        • Research Site
      • Izumi-shi, Japan, 594-0073
        • Rekruttering
        • Research Site
      • Kashihara-shi, Japan, 634-8522
        • Rekruttering
        • Research Site
      • Kobe, Japan, 650-0046
        • Rekruttering
        • Research Site
      • Kurume-shi, Japan, 830-0011
        • Rekruttering
        • Research Site
      • Kyoto, Japan, 602-8566
        • Rekruttering
        • Research Site
      • Kōtoku, Japan, 135-8550
        • Rekruttering
        • Research Site
      • Matsuyama, Japan, 791-0280
        • Rekruttering
        • Research Site
      • Nankoku-shi, Japan, 783-8505
        • Rekruttering
        • Research Site
      • Niigata, Japan, 951-8566
        • Rekruttering
        • Research Site
      • Osaka, Japan, 534-0021
        • Rekruttering
        • Research Site
      • Sakaishi, Japan, 591-8555
        • Rekruttering
        • Research Site
      • Sayama, Japan, 589-8511
        • Rekruttering
        • Research Site
      • Sendai, Japan, 980-0873
        • Rekruttering
        • Research Site
      • Shinagawa-ku, Japan, 142-8666
        • Rekruttering
        • Research Site
      • Takarazuka-shi, Japan, 665-0827
        • Rekruttering
        • Research Site
      • Toon-Shi, Japan, 791-0295
        • Rekruttering
        • Research Site
      • Toyoake-shi, Japan, 470-1192
        • Rekruttering
        • Research Site
      • Toyonaka-shi, Japan, 560-8552
        • Rekruttering
        • Research Site
      • Baoding, Kina, 071000
        • Ikke rekrutterer endnu
        • Research Site
      • Beijing, Kina, 100142
        • Ikke rekrutterer endnu
        • Research Site
      • Beijing, Kina, 100021
        • Rekruttering
        • Research Site
      • Beijing, Kina, 101149
        • Ikke rekrutterer endnu
        • Research Site
      • Bengbu, Kina, 233004
        • Rekruttering
        • Research Site
      • Changchun, Kina, 130000
        • Ikke rekrutterer endnu
        • Research Site
      • Changchun, Kina, 130033
        • Rekruttering
        • Research Site
      • Changsha, Kina, 410013
        • Ikke rekrutterer endnu
        • Research Site
      • Changsha, Kina, 410008
        • Ikke rekrutterer endnu
        • Research Site
      • Chengdu, Kina, 610041
        • Rekruttering
        • Research Site
      • Chongqing, Kina, 400042
        • Ikke rekrutterer endnu
        • Research Site
      • Chongqing, Kina, 400030
        • Ikke rekrutterer endnu
        • Research Site
      • Fuzhou, Kina, 350001
        • Rekruttering
        • Research Site
      • Fuzhou, Kina, 350014
        • Ikke rekrutterer endnu
        • Research Site
      • Guangzhou, Kina, 510080
        • Rekruttering
        • Research Site
      • Haerbin, Kina, 150081
        • Rekruttering
        • Research Site
      • Hangzhou, Kina, 310022
        • Ikke rekrutterer endnu
        • Research Site
      • Hefei, Kina, 133500
        • Rekruttering
        • Research Site
      • Hefei, Kina, 230022
        • Rekruttering
        • Research Site
      • Jiamusi, Kina, 154007
        • Rekruttering
        • Research Site
      • Jinan, Kina, 250117
        • Rekruttering
        • Research Site
      • Langfang, Kina, 65699
        • Rekruttering
        • Research Site
      • Lanzhou, Kina, 730050
        • Rekruttering
        • Research Site
      • Linyi, Kina, 276001
        • Rekruttering
        • Research Site
      • Liuzhou, Kina, 545007
        • Rekruttering
        • Research Site
      • Nanchang, Kina, 330006
        • Rekruttering
        • Research Site
      • Nanchang, Kina, 330029
        • Rekruttering
        • Research Site
      • Nanjing, Kina, 210008
        • Rekruttering
        • Research Site
      • Nanjing, Kina, 210006
        • Rekruttering
        • Research Site
      • Nanning, Kina, 530021
        • Rekruttering
        • Research Site
      • Ningbo, Kina, 315010
        • Rekruttering
        • Research Site
      • Qingdao, Kina, 266071
        • Rekruttering
        • Research Site
      • Shanghai, Kina, 200092
        • Ikke rekrutterer endnu
        • Research Site
      • Shenyang, Kina, 110042
        • Ikke rekrutterer endnu
        • Research Site
      • Shenzhen, Kina, 518116
        • Ikke rekrutterer endnu
        • Research Site
      • Suzhou, Kina, 215004
        • Rekruttering
        • Research Site
      • Taiyuan, Kina, 030000
        • Rekruttering
        • Research Site
      • Wuhan, Kina, 430060
        • Ikke rekrutterer endnu
        • Research Site
      • Wuhan, Kina, 430030
        • Ikke rekrutterer endnu
        • Research Site
      • Xuzhou, Kina, 221002
        • Rekruttering
        • Research Site
      • Yantai, Kina, 264000
        • Rekruttering
        • Research Site
      • Zhengzhou, Kina, 450008
        • Ikke rekrutterer endnu
        • Research Site
      • George Town, Malaysia, 10350
        • Rekruttering
        • Research Site
      • Kota Bharu, Malaysia, 15586
        • Rekruttering
        • Research Site
      • Kuala Lumpur, Malaysia, 50586
        • Rekruttering
        • Research Site
      • Kuala Selangor, Malaysia, 62250
        • Rekruttering
        • Research Site
      • Perai, Malaysia, 13700
        • Rekruttering
        • Research Site
      • Alcabideche, Portugal, 2755-009
        • Rekruttering
        • Research Site
      • Braga, Portugal, 4710-243
        • Rekruttering
        • Research Site
      • Coimbra, Portugal, 3000-075
        • Rekruttering
        • Research Site
      • Lisbon, Portugal, 1400-038
        • Rekruttering
        • Research Site
      • Lisbon, Portugal, 1500-650
        • Rekruttering
        • Research Site
      • Lisbon, Portugal, 1769-001
        • Rekruttering
        • Research Site
      • Loures, Portugal, 2674-514
        • Rekruttering
        • Research Site
      • Matosinhos Municipality, Portugal, 4454-509
        • Rekruttering
        • Research Site
      • Porto, Portugal, 4200-319
        • Rekruttering
        • Research Site
      • Porto, Portugal, 4200-072
        • Rekruttering
        • Research Site
      • Porto, Portugal, 4100-180
        • Rekruttering
        • Research Site
      • Bucharest, Rumænien, 022328
        • Rekruttering
        • Research Site
      • Bucharest, Rumænien, 013812
        • Rekruttering
        • Research Site
      • Bucharest, Rumænien, 30167
        • Rekruttering
        • Research Site
      • Bucharest, Rumænien, 010626
        • Rekruttering
        • Research Site
      • Craiova, Rumænien, 200385
        • Rekruttering
        • Research Site
      • Craiova, Rumænien, 200542
        • Rekruttering
        • Research Site
      • Iași, Rumænien, 700106
        • Ikke rekrutterer endnu
        • Research Site
      • Otopeni, Rumænien, 075100
        • Rekruttering
        • Research Site
      • Piteşti, Rumænien, 110283
        • Rekruttering
        • Research Site
      • Sibiu, Rumænien, 550253
        • Rekruttering
        • Research Site
      • Timișoara, Rumænien, 300239
        • Rekruttering
        • Research Site
      • Lausanne, Schweiz, 1011
        • Rekruttering
        • Research Site
      • Badajoz, Spanien, 06080
        • Rekruttering
        • Research Site
      • Badalona, Spanien, 8916
        • Rekruttering
        • Research Site
      • Barcelona, Spanien, 08028
        • Rekruttering
        • Research Site
      • Castellon, Spanien, 12002
        • Rekruttering
        • Research Site
      • Granada, Spanien, 18016
        • Ikke rekrutterer endnu
        • Research Site
      • Jaén, Spanien, 23007
        • Ikke rekrutterer endnu
        • Research Site
      • Lugo, Spanien, 27003
        • Rekruttering
        • Research Site
      • Madrid, Spanien, 28050
        • Ikke rekrutterer endnu
        • Research Site
      • Madrid, Spanien, 28040
        • Rekruttering
        • Research Site
      • Madrid, Spanien, 28041
        • Ikke rekrutterer endnu
        • Research Site
      • Málaga, Spanien, 29010
        • Rekruttering
        • Research Site
      • Oviedo, Spanien, 33006
        • Rekruttering
        • Research Site
      • Palma de Mallorca, Spanien, 07198
        • Rekruttering
        • Research Site
      • Valencia, Spanien, 46015
        • Rekruttering
        • Research Site
      • Vigo (Pontevedra), Spanien, 36312
        • Rekruttering
        • Research Site
      • Zaragoza, Spanien, 50009
        • Rekruttering
        • Research Site
      • Jinju, Sydkorea, 52727
        • Rekruttering
        • Research Site
      • Seoul, Sydkorea, 5505
        • Rekruttering
        • Research Site
      • Seoul, Sydkorea, 135-710
        • Rekruttering
        • Research Site
      • Ankara, Tyrkiet (Türkiye), 06010
        • Rekruttering
        • Research Site
      • Bakırköy, Tyrkiet (Türkiye), 34147
        • Rekruttering
        • Research Site
      • Küçükçekmece, Tyrkiet (Türkiye), 34295
        • Rekruttering
        • Research Site
      • Yüreğir, Tyrkiet (Türkiye), 01240
        • Rekruttering
        • Research Site
      • Çankaya, Tyrkiet (Türkiye), 06680
        • Rekruttering
        • Research Site
      • İzmit, Tyrkiet (Türkiye), 41380
        • Rekruttering
        • Research Site
      • Amberg, Tyskland, 92224
        • Rekruttering
        • Research Site
      • Augsburg, by, Tyskland, 86156
        • Ikke rekrutterer endnu
        • Research Site
      • Bad Saarow, Tyskland, 15526
        • Rekruttering
        • Research Site
      • Berlin, Tyskland, 12351
        • Rekruttering
        • Research Site
      • Berlin, Tyskland, 13359
        • Rekruttering
        • Research Site
      • Bonn, Tyskland, 53127
        • Rekruttering
        • Research Site
      • Braunschweig, Tyskland, 38114
        • Rekruttering
        • Research Site
      • Essen, Tyskland, 45147
        • Rekruttering
        • Research Site
      • Flensburg, Tyskland, 24939
        • Rekruttering
        • Research Site
      • Frankfurt am Main, Tyskland, 60431
        • Ikke rekrutterer endnu
        • Research Site
      • Hamburg, Tyskland, 21075
        • Rekruttering
        • Research Site
      • Heidelberg, Tyskland, 69126
        • Rekruttering
        • Research Site
      • Heilbronn, Tyskland, 74078
        • Ikke rekrutterer endnu
        • Research Site
      • Immenhausen, Tyskland, 34376
        • Rekruttering
        • Research Site
      • Koblenz, Tyskland, 56073
        • Rekruttering
        • Research Site
      • Leipzig, Tyskland, 04103
        • Ikke rekrutterer endnu
        • Research Site
      • München, Tyskland, 80336
        • Ikke rekrutterer endnu
        • Research Site
      • Neuss, Tyskland, 41462
        • Ikke rekrutterer endnu
        • Research Site
      • Offenbach, Tyskland, 63069
        • Ikke rekrutterer endnu
        • Research Site
      • Oldenburg, Tyskland, 26121
        • Rekruttering
        • Research Site
      • Remscheid, Tyskland, 42859
        • Ikke rekrutterer endnu
        • Research Site
      • Rotenburg (Wümme), Tyskland, 27356
        • Ikke rekrutterer endnu
        • Research Site
      • Schweinfurt, Tyskland, 97421
        • Rekruttering
        • Research Site
      • Trier, Tyskland, 54292
        • Ikke rekrutterer endnu
        • Research Site
      • Velbert, Tyskland, 42551
        • Rekruttering
        • Research Site
      • Wuppertal, Tyskland, 42283
        • Rekruttering
        • Research Site
      • Würselen, Tyskland, 52146
        • Ikke rekrutterer endnu
        • Research Site
      • Würzburg, Tyskland, 97080
        • Rekruttering
        • Research Site

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Aldre berettiget til at studere

18 år og ældre (Voksen, Ældre voksen)

Tager imod sunde frivillige

Ingen

Køn, der er berettiget til at studere

Alle

Beskrivelse

Inclusion Criteria:

  • Histologically or cytologically documented NSCLC (non small lung cancer), including all histological subtypes.
  • Stage IV mNSCLC (metastatic non-small cell lung cancer) (based on the American Joint Committee on Cancer Edition 8) not amenable to curative treatment.
  • Absence of sensitizing EGFR (epidermal growth factor) mutations and ALK (anaplastic lymphoma kinase) and ROS1 (c-ros oncogene 1) rearrangements. Negative assay result is required for all non-squamous histology subtypes.
  • Absence of documented tumor genomic mutation results from tests conducted as part of standard local practice in any other actionable driver oncogenes for which there are locally approved targeted 1L (first line) therapies.
  • WHO (World Health Organization)/ECOG (Eastern Cooperative Oncology Group) performance status of 0 or 1, with no deterioration over the previous 2 weeks prior to baseline at screening and prior to randomization.
  • Minimum life expectancy of 12 weeks.
  • Provision of acceptable tumor sample for the central testing prior to randomization.
  • At least one lesion not previously irradiated that qualifies as a RECIST 1.1 (Response Evaluation Criteria in Solid Tumors, Version 1.1) TL (target lesion) at baseline and can be accurately measured at baseline as ≥ 10 mm in the longest diameter (except lymph nodes, which must have short axis ≥ 15 mm) with CT (computed tomography) or MRI (magnetic resonance imaging) and is suitable for accurate repeated measurements.
  • Adequate organ and bone marrow function

Exclusion Criteria:

  • As judged by the investigator, any severe or uncontrolled systemic diseases, makes it undesirable for the participant to participate in the study or that would jeopardize compliance with the protocol.
  • History of organ transplant.
  • Active or prior documented autoimmune or inflammatory disorders requiring chronic treatment with steroids or other immunosuppressive treatment.
  • History of another primary malignancy except for malignancy treated with curative intent with no known active disease ≥ 2 years before the first dose of study intervention and of low potential risk for recurrence.
  • Presence of small cell and neuroendocrine histology components.
  • Brain metastases unless asymptomatic, stable, and not requiring steroids or anticonvulsants for at least 4 weeks prior to start of study intervention.
  • Active primary immunodeficiency/active infectious disease(s)
  • Active tuberculosis infection
  • Any prior systemic therapy received for advanced or mNSCLC (metastatic non-small cell lung cancer).
  • Any prior exposure to an anti-TIGIT (T-cell immunoglobulin and immunoreceptor tyrosine-based inhibitory motif domain) therapy or any other anticancer therapy targeting immune-regulatory receptors or mechanisms.
  • Any prior treatment with an anti-PD-1 (programmed cell death protein 1) or anti-PD-L1 (anti-programmed death-ligand 1) agent.

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

  • Primært formål: Behandling
  • Tildeling: Randomiseret
  • Interventionel model: Parallel tildeling
  • Maskning: Firedobbelt

Våben og indgreb

Deltagergruppe / Arm
Intervention / Behandling
Eksperimentel: Arm A

Drug: rilvegostomig

Administered intravenously (IV) on Day 1 of each 21-day cycle

Andre navne:
  • AZD2936
Aktiv komparator: Arm B

Drug: Pembrolizumab

Administered intravenously (IV) on Day 1 of each 21-day cycle

Andre navne:
  • KEYTRUDA

Hvad måler undersøgelsen?

Primære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Overall Survival (OS)
Tidsramme: Up to approximately 5 years

OS is defined as the time from randomization until the date of death due to any cause.

Up to approximately 5 years
Progression-Free Survival (PFS)
Tidsramme: Up to approximately 5 years

PFS is defined as the time from randomization until radiological progression per RECIST 1.1 or death due to any cause (in the absence of progression).

Up to approximately 5 years

Sekundære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Landmark Overall Survival (OS) rates
Tidsramme: Up to approximately 5 years

OS is defined as the time from randomization until the date of death due to any cause.

Up to approximately 5 years
Landmark Progression-Free Survival (PFS) rates
Tidsramme: Up to approximately 5 years

PFS is defined as the time from randomization until radiological progression per RECIST 1.1 or death due to any cause (in the absence of progression).

Up to approximately 5 years
Objective Response Rate (ORR)
Tidsramme: Up to approximately 5 years

ORR is defined as the proportion of participants who have a confirmed CR or confirmed PR, using RECIST 1.1.

Up to approximately 5 years
Duration of Response (DoR)
Tidsramme: Up to approximately 5 years

DoR is defined as the time from the date of first documented response until the date of documented progression using RECIST 1.1 or death due to any cause (in the absence of progression).

Up to approximately 5 years
Time to second progression or death (PFS2)
Tidsramme: Up to approximately 5 years

PFS2 is defined as the time from randomization until the earliest of the progression event (following the initial investigator-assessed progression event), after the start of the first subsequent therapy, or death from any cause, whichever occurs first.

Up to approximately 5 years
Pharmakokinetics (PK) of rilvegostomig
Tidsramme: Up to approximately 5 years

Concentration of rilvegostomig in serum

Up to approximately 5 years
Immunogenicity of rilvegostomig
Tidsramme: Up to approximately 5 years

Presence of antidrug antibodies (ADAs), titer, and neutralizing antibodies for rilvegostomig.

Up to approximately 5 years
Patient-reported physical functioning
Tidsramme: Up to approximately 5 years

Proportion of participants with maintained or improved physical functioning as measured by Patient-Reported Outcomes Measurement Information System Physical Function - Short Form 8c - 7 day (PROMIS PF-SF 8c - 7 day) at each time point.

Up to approximately 5 years
Patient-reported global health status (GHS)/quality of life (QoL)
Tidsramme: Up to approximately 5 years

Time to deterioration (TTD) of GHS/QoL as measured by the European Organization for Research and Treatment of Cancer Item Library 172 (EORTC IL172). TTD is defined as time from randomization to the date of first deterioration.

Up to approximately 5 years
Patient-reported lung cancer symptoms of non-small cell lung cancer (NSCLC)
Tidsramme: Up to approximately 5 years

Time to deterioration (TTD) in pulmonary symptoms as measured by the Non-Small Cell Lung Cancer Symptom Assessment Questionnaire (NSCLC-SAQ).

TTD is defined as time from randomization to the date of first deterioration.

Up to approximately 5 years

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Sponsor

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart (Faktiske)

10. april 2025

Primær færdiggørelse (Anslået)

17. januar 2030

Studieafslutning (Anslået)

2. december 2030

Datoer for studieregistrering

Først indsendt

7. marts 2025

Først indsendt, der opfyldte QC-kriterier

7. marts 2025

Først opslået (Faktiske)

10. marts 2025

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (Faktiske)

25. september 2026

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

24. september 2026

Sidst verificeret

1. september 2026

Mere information

Begreber relateret til denne undersøgelse

Plan for individuelle deltagerdata (IPD)

Planlægger du at dele individuelle deltagerdata (IPD)?

JA

IPD-planbeskrivelse

Qualified researchers can request access to anonymized individual participant-level data from AstraZeneca group of companies sponsored clinical trials via the request portal. All requests will be evaluated as per the AZ disclosure commitment:

https://astrazenecagrouptrials.pharmacm.com/ST/Submission/Disclosure.

Yes, indicates that AZ are accepting requests for IPD, but this does not mean all requests will be shared.

IPD-delingstidsramme

AstraZeneca will meet or exceed data availability as per the commitments made to the EFPIA Pharma Data Sharing Principles. For details of our timelines, please refer to our disclosure commitment at https://astrazenecagrouptrials.pharmacm.com/ST/Submission/Disclosure.

IPD-delingsadgangskriterier

When a request has been approved AstraZeneca will provide access to the anonymized individual patient-level data via secure research environment Vivli.org. A Signed Data Usage Agreement (non-negotiable contract for data accessors) must be in place before accessing requested information.

IPD-deling Understøttende informationstype

  • STUDY_PROTOCOL
  • SAP

Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter

Studerer et amerikansk FDA-reguleret lægemiddelprodukt

Ja

Studerer et amerikansk FDA-reguleret enhedsprodukt

Ingen

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .

Abonner